Four ideas to bring drug substance and drug product manufacturing back to the U.S. In a recent Contract Pharma article, I shared the challenges of working with Chinese manufacturers and questioned if these growing concerns are sparking a shift back to U.S. manufacturing. When I wrote that article, the COVID-19 crisis was mostly confined to China, yet now it has become a full-blown pandemic, which the U.S. is in the throes of today.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with SEQENS North
Contact SEQENS North, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack